AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Co-DiagnosticsIradimedCytosorbentsSeaSpineAlphatec
SymbolNASDAQ:CODXNASDAQ:IRMDNASDAQ:CTSONASDAQ:SPNENASDAQ:ATEC
Price Information
Current Price$16.93$22.15$9.89$11.78$4.94
52 Week RangeBuyN/ABuyBuyBuy
Beat the Market™ Rank
Overall Score0.81.51.51.51.4
Analysis Score1.52.03.53.43.5
Community Score2.42.43.52.71.9
Dividend Score0.00.00.00.00.0
Ownership Score0.01.00.01.01.0
Earnings & Valuation Score0.01.90.60.60.6
Analyst Ratings
Consensus RecommendationBuyN/ABuyBuyBuy
Consensus Price Target$17.00$30.00$15.25$16.50$9.63
% Upside from Price Target0.41% upside35.44% upside54.20% upside40.07% upside94.84% upside
Trade Information
Market Cap$494.23 million$274.14 million$361.21 million$293.15 million$289.80 million
Beta-2.471.310.580.941.93
Average Volume10,570,99048,781754,495230,294574,879
Sales & Book Value
Annual Revenue$220,000.00$38.52 million$24.95 million$159.08 million$113.43 million
Price / Sales2,112.946.9314.362.022.76
CashflowN/A$0.92 per shareN/AN/AN/A
Price / CashN/A24.03N/AN/AN/A
Book Value$0.10 per share$4.83 per share$0.11 per share$5.74 per share$0.71 per share
Price / Book169.304.5989.912.056.96
Profitability
Net Income$-6,200,000.00$9.63 million$-19,270,000.00$-39,280,000.00$-57,000,000.00
EPS($0.36)$0.78($0.60)($2.07)($1.09)
Trailing P/E RatioN/A28.77N/AN/AN/A
Forward P/E Ratio13.5420.70N/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-334.58%24.65%-62.65%-26.93%-54.42%
Return on Equity (ROE)-81.15%17.99%-165.86%-27.09%-167.29%
Return on Assets (ROA)-74.06%15.02%-55.40%-21.61%-37.61%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.05%0.54%0.04%1.95%
Current Ratio16.44%12.40%3.27%5.90%2.40%
Quick Ratio15.86%11.54%3.10%4.30%1.41%
Ownership Information
Institutional Ownership Percentage7.91%33.91%27.54%78.23%38.86%
Insider Ownership Percentage9.00%56.80%5.70%9.76%28.18%
Miscellaneous
Employees2295125361195
Shares Outstanding27.46 million12.05 million36.23 million27.24 million63.41 million
Next Earnings Date8/12/2020 (Estimated)8/4/2020 (Estimated)8/4/2020 (Estimated)8/6/2020 (Estimated)7/22/2020 (Estimated)
OptionableNot OptionableNot OptionableOptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.